`Tel: 571-272-7822
`
`Paper 106
`Entered: June 22, 2020
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`ACRUX DDS PTY LTD., ACRUX LIMITED, and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioner,
`v.
`KAKEN PHARMACEUTICAL CO., LTD. and VALEANT
`PHARMACEUTICALS INTERNATIONAL, INC.,
`Patent Owner.
`
`
`IPR2017-001901
`Patent 7,214,506 B2
`
`
`
`Before ERICA A. FRANKLIN, SUSAN L. C. MITCHELL, and
`ROBERT A. POLLOCK, Administrative Patent Judges.
`
`MITCHELL, Administrative Patent Judge.
`
`
`
`
`ORDER
`Conduct of the Proceeding
`37 C.F.R. § 42.5(c)(2)
`
`
`1 IPR2017-01429 was previously joined with the instant proceeding.
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2017-00190
`Patent 7,214,506 B2
`
`Petitioner Argentum Pharmaceuticals (“Argentum”) requested a
`30-day extension of time for filing its Opposition to the Motion to Terminate
`the proceeding. See Ex. 3002. Argentum has indicated that no party
`opposes the extension. Id. On June 10, 2020, we granted Argentum’s
`request for a 30-day extension of time, see id., and are entering this Order to
`confirm such grant for good cause due to logistical challenges as a result of
`the COVID-19 pandemic. See 37 C.F.R. § 42.5(c)(2); May 2020 Update
`Regarding Certain Patent-Related Timing Deadlines under the Coronavirus,
`Aid, Relief, and Economic Security Act and Other Relief Available to
`Applicants, Patent Owners, and Others (May 27, 2020),
`https://www.uspto.gov/sites/default/files/documents/Patents-Notice-
`CARES-Act-2020-05.pdf.
`
`
` ORDER
`
`Accordingly, it is
`ORDERED that the Petitioner Argentum’s Unopposed Motion for a
`30-day Extension of Time to file its Opposition to the Motion to Terminate
`the proceeding is granted.
`
`
`
`
`
`
`
`2
`
`
`
`IPR2017-00190
`Patent 7,214,506 B2
`For PETITIONER:
`
`Tara Raghavan
`Steven J. Birkos
`RAKOCZY MOLINO MAZZOCHI SIWIK
`traghavan@rmmslegal.com
`sbirkos@rmmslegal.com
`
`For PATENT OWNER:
`
`John Livingstone
`Naoki Yoshida
`Anthony Hartmann
`Barbara R. Rudolph
`Trenton Ward
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`john.livingstone@finnegan.com
`naoki.yoshida@finnegan.com
`hartmana@finnegan.com
`Barbara.rudolph@finnegan.com
`Trenton.ward@finnegan.com
`
`Toan P. Vo
`VALEANT PHARMACEUTICALS NORTH AMERICA LLC
`Toan.vo@bausch.com
`
`3
`
`